Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111 for the treatment of glaucoma. Its products pipeline also comprise NB2222 for the treatment of dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3000 for the treatment of methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is headquartered in Long Beach, California.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone949-336-3443
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees3
Next Earnings Date3/12/2020 (Estimated)
OptionableNot Optionable
OTCMKTS:EMBI (OTCMKTS:EMBI) Frequently Asked Questions
What is OTCMKTS:EMBI's stock symbol?
OTCMKTS:EMBI trades on the OTCMKTS under the ticker symbol "EMBI."
When is OTCMKTS:EMBI's next earnings date?
Has OTCMKTS:EMBI been receiving favorable news coverage?
Headlines about EMBI stock have trended negative recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. OTCMKTS:EMBI earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for OTCMKTS:EMBI.
Who are some of OTCMKTS:EMBI's key competitors?
Some companies that are related to OTCMKTS:EMBI include Vascular Biogenics (VBLT), American Brivision (Holding) (ABVC), Acer Therapeutics (ACER), Forward Pharma A/S (FWP), Zafgen (ZFGN), SUMMIT THERAPEU/S (SMMT), AgeX Therapeutics (AGE), Hoth Therapeutics (HOTH), Tiziana Life Sciences (TLSA), Bellicum Pharmaceuticals (BLCM), Acasti Pharma (ACST), Humanigen (HGEN), Pharmaxis (PXSLY), Iterum Therapeutics (ITRM) and IntelGenx Technologies (IGXT).
What other stocks do shareholders of OTCMKTS:EMBI own?
How do I buy shares of OTCMKTS:EMBI?
Shares of EMBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is OTCMKTS:EMBI's stock price today?
One share of EMBI stock can currently be purchased for approximately $0.09.
How big of a company is OTCMKTS:EMBI?
What is OTCMKTS:EMBI's official website?
How can I contact OTCMKTS:EMBI?
OTCMKTS:EMBI's mailing address is 130 NORTH MARINA DRIVE, LONG BEACH CA, 90803. The company can be reached via phone at 949-336-3443.
MarketBeat Community Rating for OTCMKTS:EMBI (OTCMKTS EMBI)
MarketBeat's community ratings are surveys of what our community members think about OTCMKTS:EMBI and other stocks. Vote "Outperform" if you believe EMBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EMBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
